- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06093087
Randomized Controlled Trial of Internal Fixation Reconstruction With Stent Screw in the Treatment of Kummell's Disease
October 19, 2023 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
Internal Fixation Reconstruction With Stent Screw VS Balloon Kyphoplasty in the Treatment of Kummell's Disease: a Double Blinded Randomized Controlled Trial
This study is a multicenter, prospective, double-blind, randomized controlled trial using a parallel two-arm design to investigate whether the postoperative 6-month quality of life, vertebral stability, complication of patients with osteoporotic vertebral compression fractures (Kummell's disease) are better with the use of stent screw internal fixation and percutaneous bone cement reconstruction technique compared to patients undergoing traditional percutaneous balloon kyphoplasty (BKP) for vertebral augmentation
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wanli Li, MD
- Phone Number: +86 13967116021
- Email: liwanli@zju.edu.cn
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 60 or above, gender not specified.
- Must have one to three vertebral segments with vertebral compression fracture (VCF) located between T5 and L5, attributed to underlying primary or secondary osteoporosis rather than cancer.
- All VCFs must exhibit the following radiographic changes: according to Genant's criteria, acute (≤4 months) decrease in anterior, middle, or posterior vertebral height by at least one grade (20-25% reduction in vertebral height, 10-20% reduction in vertebral area) compared to previous X-ray, CT, or MRI results.
- All VCFs for treatment must occur within four months or less.
- All VCFs for treatment must be technically feasible and clinically suitable for BKP or SAIF surgery.
- Pre-treatment back pain NRS score must be ≥ 7 and ineffective with conservative (non-surgical) treatment.
- Pre-treatment Oswestry Disability Index must be ≥ 30 (on a scale of 0-100).
- Patient's life expectancy must be ≥ 12 months.
- Must declare willingness to participate in all post-operative follow-ups.
- Must be capable of understanding the risks and benefits of the study and willing to provide written informed consent.
Exclusion Criteria:
- Vertebral morphology or fracture morphology unsuitable for balloon kyphoplasty. VCF caused by high-energy trauma.
- Asymptomatic VCF or vertebral bodies amenable to prophylactic treatment.
- VCF at the same site associated with primary bone tumors.
- Back pain caused by reasons other than acute fractures. VCF with an estimated fracture time of more than 4 months, based on clinical assessment (radiological evidence and patient history).
- VCF associated with secondary radiculopathy or neurological compromise.
- VCF requiring spinal surgery other than BKP or SAIF.
- Spinal cord compression or vertebral canal injury requiring decompression surgery.
- Combined clinical conditions unsuitable for surgery or affecting subsequent long-term data collection or follow-up.
- Allergy to any component during the surgical procedure (e.g., bone cement, contrast agents).
- Concurrent participation in another clinical study.
- Pregnancy during the study or planning to become pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SAIF
patients will be treated with kyphoplasty surgery combined with pedicular screw-assisted internal fixation for vertebral augmentation
|
The patient was placed in a prone position under general anesthesia.
Using a C-arm X-ray machine and a positioning plate for navigation, the target position on the vertebral body was located one the surface of the body.
The puncture needle core was withdrawn after puncturing, and a guide needle was inserted.
After removing the puncture needle sleeve, a hollow bone cement screw was screwed into the anterior column of the vertebral body through the guide needle.
Subsequently, bone cement was injected into the appropriate position through the bone cement screw to restore the vertebral height
|
|
Active Comparator: BKP
patients will be treated with balloon kyphoplasty surgery for vertebral augmentation
|
The patient was placed in a prone position after general anesthesia.
Using a C-arm X-ray machine and a positioning plate for guidance, the target position on the vertebral body was located from the surface of the body.
A puncture needle sleeve was inserted into the vertebral body.
A PKP balloon was then inserted to perform vertebral restoration.
After removing the balloon, an appropriate amount of bone cement was injected to ensure even distribution within the vertebral body.
Vertebral height augmentation and restoration will then be achieved.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ODI score
Time Frame: ODI score measured 1,3,6 months post surgery during follow up
|
Each patients were asked to complete the Oswestry Disability Index questionnaire postoperatively during follow up
|
ODI score measured 1,3,6 months post surgery during follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CT imaging indicators related to vertebral body stability
Time Frame: all variables were measured 1,3,6 months post surgery during follow up
|
There are total 5 indicators measured based on CT images: Anterior vertebral height (ant VBH), middle vertebral height (mid VBH), posterior vertebral height (post VBH), vertebral kyphosis angle (VKA), local kyphosis angle (LKA)
|
all variables were measured 1,3,6 months post surgery during follow up
|
|
SF36 score
Time Frame: measured 1,3,6 months post surgery during follow up
|
SF-36 questionnaire aimed at two different constructs to measure health-related quality of life: the Physical Component and the Mental Component
|
measured 1,3,6 months post surgery during follow up
|
|
VAS score
Time Frame: measured 1,3,6 months post surgery during follow up
|
The Visual Analogue Scale (VAS) measures pain intensity.
0 indicates no pain and 10 indicates pain as bad as it could possibly be
|
measured 1,3,6 months post surgery during follow up
|
|
EQ-5D score
Time Frame: measured 1,3,6 months post surgery during follow up
|
The EQ-5D descriptive system measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
|
measured 1,3,6 months post surgery during follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2024
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
September 1, 2027
Study Registration Dates
First Submitted
October 19, 2023
First Submitted That Met QC Criteria
October 19, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Actual)
October 23, 2023
Last Update Submitted That Met QC Criteria
October 19, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LWL_2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporotic Vertebral Compression Fracture
-
Igor MovrinCompletedOsteoporotic Vertebral Compression FractureSlovenia
-
Icahn School of Medicine at Mount SinaiTerminatedVertebral Compression Fractures | Osteoporotic Vertebral Compression FracturesUnited States
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
Shenzhen People's HospitalCompletedOsteoporotic Vertebral Compression FractureChina
-
Wiltrom Co., Ltd.AvaniaActive, not recruitingOsteoporotic Vertebral Compression FracturesGermany
-
Eva Koetsier MD PhDProf. Dr. Med. Alessandro Cianfoni, MD PhD, Neurocenter of Southern Switzerland...Not yet recruitingUnstable Osteoporotic Vertebral Compression FracturesSwitzerland
-
Stryker InstrumentsTalosixCompleted
-
University of VirginiaCook Group Incorporated; ArthroCare Corporation; Cardinal HealthCompletedOsteoporotic Vertebral Compression FracturesUnited States
-
University Hospital, Strasbourg, FranceUnknownVertebral Compression Fractures in Osteoporotic PatientsFrance
-
University Hospital, BonnUnknownOsteoporotic Vertebral Compression Fractures | Lung FunctionGermany
Clinical Trials on SAIF
-
Tan Tock Seng HospitalNanyang Technological UniversityCompleted
-
Eva Koetsier MD PhDProf. Dr. Med. Alessandro Cianfoni, MD PhD, Neurocenter of Southern Switzerland...Not yet recruitingUnstable Osteoporotic Vertebral Compression FracturesSwitzerland